prostate%20cancer
PROSTATE CANCER

Prostate cancer is the cancer that occurs in the male's prostate.

It is the most common cancer in men >50 years of age.

Signs and symptoms include weak urinary stream, polyuria, nocturia, hematuria, erectile dysfunction, pelvic pain, back pain, chest pain, lower extremity weakness or numbness and loss of bowel or bladder control.

Drug Information

Indication: Metastatic breast cancer. Advanced ovarian cancer in women who have failed a 1st-line platinum-based chemother...

Indication: Advanced prostate cancer in combination w/ LHRH analogue therapy or surgical castration.

Indication: Palliative treatment of hormone-dependent advanced prostate cancer. High-risk localized & locally advanced...

Indication: Locally advanced or metastatic breast cancer after failure of cytotoxic therapy. In combination w/ doxorubicin...

Indication: Breast, gastric, ovarian, small cell lung & superficial bladder (Tis, Ta) cancer, Non-Hodgkin's lymphoma, ...

Indication: Adult men w/ metastatic castration-resistant prostate cancer who are asymptomatic or mildly symptomatic after ...

Indication: In combination w/ prednisone or prednisolone for the treatment of metastatic castration resistant prostate can...

Indication: Regression in neoplastic conditions eg, acute leukaemia, Wilms' tumour, neuroblastoma, soft tissue & bone ...

Indication: Monotherapy or in combination w/ other chemotherapeutic agents in the treatment of metastatic non-seminomatous...

Indication: Locally advanced or metastatic prostate cancer. Genital & extragenital stage I-IV endometriosis. Precociou...

1  /  6
Editor's Recommendations
Most Read Articles
12 Mar 2019
Parasacral percutaneous electrical nerve stimulation is a safe and effective short-term approach for treating overactive bladder (OAB) in children, reports a new study.